文献速递重症综合管理与镇静镇痛

参与重症医学随机试验的学术型与社区型ICU:患者特征与试验指标比较

Academic and Community ICUs Participating in a Critical Care Randomized Trial: A Comparison of Patient Characteristics and Trial Metrics.
PubMed 文献 · Crit Care Explor · 2022-11-18
一句话结论在PROSPECT试验中,社区医院ICU患者较学术型ICU患者年龄更大、ICU住院更长、ICU与住院死亡率更高,但知情同意率、入组速度与方案依从性相似。

本研究为嵌套于PROSPECT随机对照试验(益生菌对比安慰剂用于机械通气患者)的预设观察性研究,比较加拿大34家学术型医院(入组2203例,86.2%)与7家社区医院(入组352例,13.8%)ICU机械通气患者的特征、干预、结局与试验指标。社区医院患者年龄更大(平均62.7岁 vs 59.5岁,p=0.044)、ICU住院更长(中位13天 vs 11天,p=0.012),ICU死亡率(30.4% vs 20.5%,p=0.002)和住院死亡率(40.6% vs 26.1%,p<0.001)更高。知情同意率(85.9% vs 76.3%,p=0.149)、月均入组速度(2.1 vs 1.1,p=0.119)和方案依从性(90.6% vs 91.6%,p=0.207)在社区与学术型ICU间相似。作者认为社区医院能开展高质量研究,但患者特征差异提示需更广泛纳入社区医院以保证结果外推性。

要点

  • PROSPECT试验中社区医院ICU患者较学术型ICU患者年龄更大(平均62.7岁 vs 59.5岁,p=0.044)、ICU住院更长(中位13天 vs 11天,p=0.012)。
  • 社区医院ICU患者ICU死亡率30.4%(95%CI 25.8-35.4%)vs 学术型20.5%(95%CI 18.9-11.3%),p=0.002;住院死亡率40.6%(95%CI 35.6-45.8%)vs 26.1%(95%CI 24.3-27.9%),p<0.001。
  • 知情同意率社区85.9% vs 学术型76.3%(p=0.149)、月均入组速度2.1 vs 1.1(p=0.119)、方案依从性90.6% vs 91.6%(p=0.207),差异均未达统计学显著。
  • 作者认为社区医院能开展高质量研究,试验指标与学术型医院相似,但患者特征差异提示需更广泛纳入社区医院以保证结果外推性。

适用人群与场景

  • 参与PROSPECT随机对照试验的加拿大ICU机械通气患者(PROSPECT为益生菌对比安慰剂用于机械通气患者的随机对照试验)。
  • 纳入分析的医院为34家学术型医院和7家社区医院。

研究设计与关键结果

  • 研究类型:预设的观察性研究,嵌套于PROSPECT随机对照试验研究项目。
  • 中心与样本量:34家(82.9%)学术型医院和7家(17.1%)社区医院,分别入组2203例(86.2%)和352例(13.8%)患者。
  • 年龄:社区医院患者平均62.7岁(标准差14.9岁)vs 学术型医院59.5岁(标准差16.4岁),p=0.044。
  • ICU住院时长:社区医院中位13天(四分位距8-23天)vs 学术型医院11天(四分位距7-8天),p=0.012。
  • ICU死亡率:社区医院30.4%(95%CI 25.8-35.4%)vs 学术型医院20.5%(95%CI 18.9-11.3%),p=0.002。
  • 住院死亡率:社区医院40.6%(95%CI 35.6-45.8%)vs 学术型医院26.1%(95%CI 24.3-27.9%),p<0.001。
  • 试验指标:知情同意率社区医院85.9% vs 学术型医院76.3%,p=0.149;月均入组速度平均2.1(标准差1.4)vs 1.1(标准差0.7),p=0.119;方案依从性90.6% vs 91.6%,p=0.207。

证据类型、等级与局限

  • 证据类型:预设的观察性研究,嵌套于PROSPECT随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为社区医院能开展高质量研究,试验指标与学术型医院相似。
  • 作者认为患者特征在社区与学术型医院间存在差异,提示需更广泛纳入社区医院以保证研究结果的外推性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Clinical research in Canada is conducted primarily in "academic" hospitals, whereas most clinical care is provided in "community" hospitals. The objective of this nested observational study was to compare patient characteristics, outcomes, process-of-care variables, and trial metrics for patients enrolled in a large randomized controlled trial who were admitted to academic and community hospitals in Canada.

DESIGN: We conducted a preplanned observational study nested within the Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT, a randomized controlled trial comparing probiotics to placebo in mechanically ventilated patients) Research Program.

PATIENTS: Mechanically ventilated patients.

MEASUREMENTS: We compared patient characteristics, interventions, outcomes, and trial metrics between patients enrolled in PROSPECT from academic and community hospitals.

MAIN RESULTS: Participating centers included 34 (82.9%) academic and seven (17.1%) community hospitals, which enrolled 2,203 (86.2%) and 352 (13.8%) patients, respectively. Compared with academic hospitals, patients enrolled in community hospitals were older (mean [sd] 62.7 yr [14.9 yr] vs 59.5 yr [16.4 yr]; p = 0.044), had longer ICU stays (median [interquartile range {IQR}], 13 d [8-23 d] vs 11 d [7-8 d]; p = 0.012) and higher mortality (percentage, [95% CI] in the ICU, 30.4% [25.8-35.4%]vs 20.5% [18.9-11.3%]; p = 0.002) and hospital (40.6% [35.6-45.8%] vs 26.1% [24.3-27.9%]; p < 0.001). Trial metrics, including informed consent rate (85.9% vs 76.3%; p = 0.149), mean (sd) monthly enrolment rate (2.1 [1.4] vs 1.1 [0.7]; p = 0.119), and protocol adherence (90.6% vs 91.6%; p = 0.207), were similar between community and academic ICUs.

CONCLUSIONS: Community hospitals can conduct high-quality research, with similar trial metrics to academic hospitals. Patient characteristics differed between community and academic hospitals, highlighting the need for broader engagement of community hospitals in clinical research to ensure generalizability of study results.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Tsang JLY, Binnie A, Duan EH, et al. Academic and Community ICUs Participating in a Critical Care Randomized Trial: A Comparison of Patient Characteristics and Trial Metrics. Crit Care Explor. 2022. PMID: 36419633. doi:10.1097/CCE.0000000000000794

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。